A new report has found that the cost of prescription drugs for treating metabolic conditions such as type 2 diabetes in the United States increased to USD52.2 billion during 2008. The Agency for Healthcare Research and Quality (AHRQ), in its most recent News and Numbers publication, said that consumers and insurers spent USD52.2 billion on prescription drugs in that year for outpatient treatment of metabolic conditions such as diabetes and elevated cholesterol .
The findings from the federal agency also revealed that treatments for metabolic conditions were the type of therapies that had the highest level of spending in 2008, with US adults purchasing metabolic drugs totalling 22 per cent of the almost USD233 billion that is spent through the year on prescription medicines .
Purchases on the main therapeutic classes of drug treatments amounted to almost USD156 billion, of the nearly USD233 billion spent on prescription medicines used in the outpatient treatment of adults.
It was also revealed that drugs used to treat the central nervous system for chronic pain, epileptic seizures and Parkinsons disease amounted to USD35 billion, that cardiovascular drugs totalled USD29 billion in spend, that antacids, antidiarrheals, and other drugs for gastrointestinal conditions cost USD20 billion, and that USD20 billion was spent on antidepressants, antipsychotics and other psychotherapeutic drugs.
Increase in prescription costs for diabetes drugs in US
Mon, 28 Feb 2011
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.
Also related to this storyDiabetes Chat
Healthcare Professionals and Diabetes
Diabetes and Financial Services
Diabetes and Pensions
Diabetes and Cholesterol
Diabetes and Pregnancy
Diabetes and Obesity
The Diet Plate
Free Blood Sugar Meter Giveaway
Diabetes Guides for Patients in India
Diabetes drugs could help combat lung cancer
New diabetes drugs being developed
Diet and exercise better than drugs for reducing heart risks in diabetics
Popular Cholesterol drugs increase diabetes risk
Lack of sugar molecule raises chance of diabetes onset
New research into unchecked gene for diabetes treatment
Many diagnoses of children with diabetes can be missed, says report
Low amounts of aspirin could reduce risk of type 2 diabetes atherosclerosis
No link found between diabetes and vitamin D, according to study
Diamyd vaccine to stop diabetes completes European trial
High blood sugar levels for diabetes patients in hospital not a danger
Diabetes alert issued concerning Alco-Prep swabs
Type 1 diabetes frequently diagnosed late after onset of dangerous DKA
Brain insulin could be factor in diabetes risk
Diabetes charity calls for changes to government health bill
Preadolescent children with type 1 diabetes more prone to heart disease, says report
Focus on those at risk from diabetes in new study
Diabetes treatment using regulatory protein being trialled